Pricing and reimbursement activities for the French market

Case studies - 18 February 2021

Pricing and reimbursement activities for the French market

A global company recently entrusted to BlueReg the management of pricing and reimbursement activities to bring their product on the French market.


Pricing and reimbursement strategy and activities are specific to each country. In France, the positioning of the product as compared to competitors, the presentation of data, their robustness (…) are key in the evaluation process. P&R activities are key activities for each company. A good understanding of the French market, of the process of evaluation, of past delivered opinions by involved authorities (HAS and CEPS) are crucial points. The results of negotiations with HAS and CEPS may determine the decision of the pharmaceutical company to launch the product in France or not.

Did you like this article? Share on social networks:

    By sending this form, I agree that my personal data will be saved and processed according to data protection regulations and will be used only for commercial and marketing purposes only.

    Learn more

    BlueReg undertakes to comply with the regulations in force applicable to the processing of personal data and, in particular, Regulation (EU) 2016/679 of the European Parliament and of the Council of 27 April 2016 applicable as from 25 May 2018 (hereinafter, "the General Data Protection Regulations" or GPDR) and the national laws resulting therefrom.
    Any inquiries, correction or declaration of event related to personal data processed should be sent to: GDPR data request

    Thank you for your reply

    The file will be sent to you by email.